Nestle to Pay $2 Billion to Own Aimmune Therapeutics Which Produces Peanut Allergy Treatment WATCH: Nestle to pay $2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics https://t.co/PhBhLklNTj pic.twitter.com/2Um0VMK9Uk— Reuters (@Reuters) September 6, 2020 Nestle Peanut Allergy
